Ubs Group Ag Zynex Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Zynex Inc stock. As of the latest transaction made, Ubs Group Ag holds 5,380 shares of ZYXI stock, worth $43,954. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,380

Previous 10,598 49.24%

Holding current value

$43,954

Previous $98,000 56.12%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.19 - $10.31 $37,517 - $53,797	-5,218 Reduced 49.24%	5,380 $43,000
Q2 2024 Aug 13, 2024	SELL	$8.63 - $12.56 $63,672 - $92,667	-7,378 Reduced 41.04%	10,598 $98,000
Q1 2024 May 13, 2024	SELL	$9.86 - $13.74 $25,458 - $35,476	-2,582 Reduced 12.56%	17,976 $222,000
Q4 2023 Feb 09, 2024	SELL	$7.1 - $10.89 $13,113 - $20,113	-1,847 Reduced 8.24%	20,558 $223,000
Q3 2023 Nov 09, 2023	BUY	$6.95 - $9.89 $46,856 - $66,678	6,742 Added 43.04%	22,405 $179,000
Q2 2023 Aug 11, 2023	BUY	$8.59 - $14.56 $36,593 - $62,025	4,260 Added 37.36%	15,663 $150,000
Q1 2023 May 12, 2023	BUY	$9.53 - $16.8 $55,493 - $97,826	5,823 Added 104.35%	11,403 $136,000
Q4 2022 Feb 08, 2023	BUY	$8.71 - $14.28 $1,820 - $2,984	209 Added 3.89%	5,580 $77,000
Q3 2022 Nov 10, 2022	BUY	$7.19 - $9.91 $12,697 - $17,501	1,766 Added 48.99%	5,371 $49,000
Q2 2022 Aug 10, 2022	SELL	$5.78 - $8.87 $370,833 - $569,081	-64,158 Reduced 94.68%	3,605 $29,000
Q1 2022 May 16, 2022	SELL	$5.14 - $9.35 $32,556 - $59,222	-6,334 Reduced 8.55%	67,763 $423,000
Q4 2021 Feb 14, 2022	SELL	$8.71 - $13.77 $202,228 - $319,711	-23,218 Reduced 23.86%	74,097 $739,000
Q3 2021 Nov 15, 2021	BUY	$10.35 - $15.65 $440,558 - $666,157	42,566 Added 77.75%	97,315 $1.11 Million
Q2 2021 Aug 13, 2021	SELL	$12.25 - $14.87 $40,449 - $49,100	-3,302 Reduced 5.69%	54,749 $850,000
Q1 2021 May 12, 2021	SELL	$12.28 - $19.74 $461,384 - $741,671	-37,572 Reduced 39.29%	58,051 $887,000
Q4 2020 Feb 11, 2021	BUY	$11.65 - $17.94 $326,467 - $502,732	28,023 Added 41.45%	95,623 $1.29 Million
Q3 2020 Nov 12, 2020	BUY	$12.98 - $25.98 $602,401 - $1.21 Million	46,410 Added 219.02%	67,600 $1.18 Million
Q2 2020 Jul 31, 2020	BUY	$9.06 - $23.49 $92,638 - $240,185	10,225 Added 93.25%	21,190 $527,000
Q1 2020 May 01, 2020	SELL	$7.2 - $13.09 $70,099 - $127,444	-9,736 Reduced 47.03%	10,965 $121,000
Q4 2019 Feb 14, 2020	BUY	$6.94 - $11.37 $55,478 - $90,891	7,994 Added 62.91%	20,701 $163,000
Q3 2019 Nov 14, 2019	BUY	$6.69 - $9.65 $58,858 - $84,900	8,798 Added 225.07%	12,707 $120,000
Q2 2019 Aug 14, 2019	BUY	$4.23 - $10.66 $11,882 - $29,943	2,809 Added 255.36%	3,909 $35,000
Q1 2019 May 14, 2019	BUY	$2.56 - $5.06 $2,816 - $5,566	1,100 New	1,100 $5,000

Others Institutions Holding ZYXI

# of Institutions

103

Shares Held

8.4M

Call Options Held

200

Put Options Held

1.5K

View Full List

About ZYNEX INC

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $306M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

More about ZYXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account